JERSEY CITY, N.J., May 05, 2022--Organon (NYSE: OGN) (the "company"), today announced its results for the first quarter ended March 31, 2022.
JERSEY CITY, N.J., April 21, 2022--Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
JERSEY CITY, N.J. & SAN DIEGO, March 31, 2022--Organon Enters into Global License Agreement to commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%)